|
SVIP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.87860837996823E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.12196926696606E-12 |
| Normal-vs-Stage2 |
1.90480999999743E-05 |
| Normal-vs-Stage3 |
2.8235191962267E-12 |
| Normal-vs-Stage4 |
3.27404769961959E-12 |
| Stage1-vs-Stage2 |
9.910800E-01 |
| Stage1-vs-Stage3 |
4.037600E-01 |
| Stage1-vs-Stage4 |
5.521500E-03 |
| Stage2-vs-Stage3 |
6.604800E-01 |
| Stage2-vs-Stage4 |
1.193240E-01 |
| Stage3-vs-Stage4 |
1.387970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62847513252018E-12 |
| Normal-vs-AfricanAmerican |
1.10140000453285E-08 |
| Normal-vs-Asian |
2.002000E-04 |
| Caucasian-vs-AfricanAmerican |
1.399570E-01 |
| Caucasian-vs-Asian |
6.181400E-01 |
| AfricanAmerican-vs-Asian |
9.138400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.13429999837322E-08 |
| Male-vs-Female |
4.860900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.11690023685674E-10 |
| Normal-vs-Extreme_Weight |
2.02970973361971E-12 |
| Normal-vs-Obese |
2.51800025274918E-10 |
| Normal-vs-Extreme_Obese |
5.003400E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.681200E-01 |
| Normal_Weight-vs-Obese |
5.795600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.971600E-01 |
| Extreme_Weight-vs-Obese |
3.326400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.654600E-01 |
| Obese-vs-Extreme_Obese |
9.551800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.73190000000356E-05 |
| Normal-vs-Age(41-60Yrs) |
1.80966353013901E-14 |
| Normal-vs-Age(61-80Yrs) |
1.69630975932478E-12 |
| Normal-vs-Age(81-100Yrs) |
2.31529995176061E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.729200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.702200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.246300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.487000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.855630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.362800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63169477929159E-12 |
| Normal-VS-Type2 PRCC |
1.12243547789603E-12 |
| Normal-VS-KIRP CIMP |
1.173080E-04 |
| Normal-VS-Unclassified PRCC |
2.988498337686E-12 |
| Type1 PRCC-VS-Type2 PRCC |
6.431000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.161600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.915400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.680980E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.227600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.023780E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.44089209850063E-16 |
| Normal-vs-N1 |
2.54629983764687E-10 |
| Normal-vs-N2 |
3.50550000000061E-05 |
| N0-vs-N1 |
1.827630E-01 |
| N0-vs-N2 |
5.899000E-01 |
| N1-vs-N2 |
1.990560E-01 |
|
|
